Rendering

Component: (Network and Table)
Network
100650 - Disclosure - Income Taxes Deferred tax assets and deferred tax liabilities (Details)
(http://www.agenusbio.com/20161231/taxonomy/role/DisclosureIncomeTaxesDeferredTaxAssetsAndDeferredTaxLiabilitiesDetails)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001098972 (http://www.sec.gov/CIK)
Income Tax Disclosure [Abstract]Period [Axis]
2016-12-31
2015-12-31
Income Tax Disclosure [Abstract]
 
 
U.S. Federal and State net operating loss carryforwards
241,572,000  
221,139,000  
Foreign net operating loss carryforwards
13,075,000  
8,412,000  
Research and development tax credits
17,723,000  
19,475,000  
Share-based compensation
13,165,000  
10,339,000  
Other
15,513,000  
7,123,000  
Total deferred tax assets
301,048,000  
 
266,488,000  
 
Less: valuation allowance
(295,502,000) 
(260,057,000) 
Net deferred tax assets
5,546,000  
 
6,431,000  
 
Deferred tax liabilities
(6,197,000) 
(7,093,000) 
Net deferred tax liability
(651,000) 
 
(662,000)